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A B S T R A C T
Adipic acid is a platform chemical, and is the most important commercial dicarboxylic acid. It has been targeted
for biochemical conversion as an alternative to present chemical production routes. From the perspective of
bioeconomy, several kinds of raw material are of interest including the sugar platform (derived from starch,
cellulose or hemicellulose), the lignin platform (aromatics) and the fatty acid platform (lipid derived). Two main
biochemical-based production schemes may be employed: (i) direct fermentation to adipic acid, or (ii) fer-
mentation to muconic or glucaric acid, followed by chemical hydrogenation (indirect fermentation). This review
presents a comprehensive description of the metabolic pathways that could be constructed and analyzes their
respective theoretical yields and metabolic constraints. The experimental yields and titers obtained so far are
low, with the exception of processes based on palm oil and glycerol, which have been reported to yield up to 50 g
and 68 g adipic acid/L, respectively. The challenges that remain to be addressed in order to achieve industrially
relevant production levels include solving redox constraints, and identifying and/or engineering enzymes for
parts of the metabolic pathways that have yet to be metabolically demonstrated. This review provides new
insights into ways in which metabolic pathways can be constructed to achieve eﬃcient adipic acid production.
The production host provides the chassis to be engineered via an appropriate metabolic pathway, and should
also have properties suitable for the industrial production of adipic acid. An acidic process pH is attractive to
reduce the cost of downstream processing. The production host should exhibit high tolerance to complex raw
material streams and high adipic acid concentrations at acidic pH.
1. Introduction
Greenhouse gas levels in the atmosphere have increased over recent
decades to levels not previously experienced in modern times, leading
to global warming which threatens to change the world's climate and
life on Earth as we know it today (Figueres et al., 2017; Rockström
et al., 2009). To reduce or avoid the consequences of climate change it
is necessary to reduce our dependency on petrochemicals, and ulti-
mately switch from a petrochemical-based economy to a biobased
economy. In a biobased economy, biomass is used as the raw material
for the production of fuels, chemicals, other materials and energy car-
riers. Adopting a biobased economy involves many, if not all, sectors of
society. Not only the techniques and processes used for energy gen-
eration for heating and fueling of our vehicles will have to be replaced
with new ones, but also those used in the chemical industry for the
production of commodity chemicals. Commodity chemicals, including a
range of both organic and inorganic products, are produced on a large
scale to satisfy the global market. Considerable eﬀorts are being de-
voted to developing methods for the production of chemicals from
biomass and to meet the demands of a growing bioeconomy. An EU
survey (E4tech et al., 2015) demonstrates this rapid development, with
examples of chemicals produced through biological or chemical routes,
or combinations of both. Process development has reached diﬀerent
levels of technology readiness, and continued eﬀort is required.
Adipic acid is considered by the International Energy Agency (IEA)
to be the most important dicarboxylic acid from an industrial point of
view, and has been identiﬁed as a suitable platform chemical for bio-
based production (de Jong et al., 2012). The amount of adipic acid
produced worldwide per year is nearly 3 million tonnes, with a market
value of almost USD 6 billion, growing at a compound annual growth
rate of 3–5%. Most adipic acid is used in the nylon industry, while lower
amounts are used in the production of plasticizers and polyurethanes,
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but it is also used in other areas, including the food and pharmaceutical
industries (Fig. 1). Historically, adipic acid was derived by the oxida-
tion of various fats, thus the name adipic acid (from the Latin adipis,
adeps meaning fat) (Ince, 1895). The current production routes rely on
petrochemical precursors, the most common route starting with the
hazardous compound benzene (Polen et al., 2013). In the ensuing re-
actions benzene is ﬁrst reduced to cyclohexane, which is oxidized to KA
oil (ketone-alcohol oil, a mixture of the ketone cyclohexanone and the
alcohol cyclohexanol). The KA oil is ﬁnally reacted with nitric acid and
air to yield adipic acid. During the ﬁnal reaction, the highly potent
greenhouse gas nitrous oxide (N2O) is formed which is nearly 300 times
more potent than carbon dioxide (CO2). It has been estimated that re-
placing the current petrochemical-based process with one employing
renewable precursors will reduce greenhouse gas emissions by up to
95%, depending on the process used (Aryapratama and Janssen, 2017;
Diamond et al., 2014).
To realize a biobased economy, the eﬃcient production and use of
biomass are necessary. Furthermore, the raw material used in a
bioeconomy must be produced in a sustainable manner. In the early
development of bioethanol production, sucrose- and starch-based raw
materials were used, which led to a conﬂict between food and feed
production and fuel production. In recent years, development has fo-
cused on the use of lignocellulosic materials, such as agricultural and
forestry residues and dedicated energy crops, as these do not compete
with food production. Lignocellulosic material is composed of the
polymers cellulose, hemicellulose and lignin. Cellulose and hemi-
cellulose can be hydrolyzed to give a sugar platform from which the
desired products can be produced. Due to its recalcitrant and hetero-
geneous nature, lignin has traditionally been considered a waste pro-
duct in bioreﬁneries, usually burned for energy production. However,
valorization of lignin can play a key role in the viability of some bio-
based processes. Lignin is a polymer consisting of aromatic units, and
has been tested as a feedstock for the biological production of muconic
acid, which can be further converted into adipic acid (Ragauskas et al.,
2014). Alternative biobased raw materials may be derived from lipids,
such as palm oil, although conﬂict may arise if the lipid-derived source
could also be used in food or feed applications.
Biobased production of adipic acid is currently being developed
(Beardslee and Picataggio, 2012; Diamond et al., 2014), and three main
production routes are emerging: 1) chemical processes, 2) indirect
fermentation combined with chemical conversion, and 3) direct fer-
mentation. In the ﬁrst case, the company Rennovia has been producing
bio-adipic acid through a chemo-catalytic process using glucose as
feedstock. During this non-biotechnological process, glucose is ﬁrst
oxidized aerobically to glucaric acid, after which the glucaric acid un-
dergoes hydrodeoxygenation to produce adipic acid. Although the
process reached pilot scale, it resulted in a mixture of components and
the yield obtained was around 60% (Boussie et al., 2013; Diamond
et al., 2014). In the second kind of route, indirect fermentation, the
precursors muconic or glucaric acid are produced, which then undergo
chemical dehydrogenation to form adipic acid (Weber et al., 2012). In
the third kind of process, direct fermentation, the raw material is di-
rectly converted to adipic acid using microbes (often referred to as the
production host). Such a process is used by the company Verdezyne
which used a genetically modiﬁed yeast species for the conversion of
fatty acids, such as coconut oil, into adipic acid (Beardslee and
Picataggio, 2012). Further development for producing adipic acid using
cheaper raw materials is in a dire need especially with recent and un-
fortunate cease of operations and exit for both Verdezyne and Rennovia
(de Guzman, 2018a, 2018b). Although several pathways have been
proposed and tested for the production of adipic acid by the direct
fermentation of sugars, they have been found to be less successful, with
titers and yields far below those required for industrial production
(Babu et al., 2015; Bart and Cavallaro, 2015; Deng et al., 2016; Deng
and Mao, 2015; Kallscheuer et al., 2017; Kruyer and Peralta-Yahya,
2017; Polen et al., 2013; Turk et al., 2016; Yu et al., 2014). However,
the potential of sugar-based production of adipic acid is considerable,
bearing in mind the maximum theoretical yields for several of the
proposed pathways, and the great abundance of carbohydrate-based
raw materials. To provide guidance in the choice of a suitable metabolic
pathway for adipic acid production, an in-depth analysis of the diﬀerent
metabolic pathways possible is useful. Not only the metabolic pathways
are important, but also the choice of raw material(s) and the production
host. Historically, hosts including natural and recombinant bacteria,
yeasts and ﬁlamentous fungi have been identiﬁed and developed for the
production of various compounds. However, there are no known eﬃ-
cient natural producers of adipic acid, and recombinant producers
must, therefore, be developed.
The aim of this review is to provide thorough insight into microbial,
biobased adipic acid production, including the selection of the pro-
duction host, the raw material and metabolic pathway. The main focus
is on metabolic pathways for the production of adipic acid, including an
extensive and detailed analysis of all currently known metabolic path-
ways via direct and indirect fermentation. Pathway-speciﬁc limitations
concerning, for example, redox balance and lack of enzymatic activities
for each of the pathways, are identiﬁed and discussed, together with the
potential for each pathway. The authors hope that aspects elucidated in
this review will help to overcome obstacles and facilitate the realization
of eﬃcient, microbial biobased adipic acid production in the future.
Fig. 1. The structure of adipic acid and examples of its uses.
Fig. 2. Dicarboxylic acids of industrial relevance naturally produced by microorganisms. Their total global annual production volumes are given in kilo tonnes (ktpa).
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2. The production host
Apart from adipic acid, other dicarboxylic acids interesting for
commercial, biobased production are, fumaric, succinic, malic and
itaconic acid (Fig. 2). Contrary to adipic acid, the mentioned acids are
all naturally produced by microorganisms (Brown et al., 2013; Song
and Lee, 2006; Wang et al., 2016; Xu et al., 2012). Although constant
eﬀorts in microbial strain engineering and improved fermentation
conditions to achieve as eﬃcient bioprocesses as possible (Chisti, 2006;
Stanbury et al., 2013) fumaric and malic acids are yet not commercially
produced. Although biobased commercial production of dicarboxylic
acids still have many obstacles to overcome the recent commersializa-
tion of succinic acid is encouraging (BASF, 2014). In below sections we
will brieﬂy describe important requirements posed on the production
host for biobased commercial production of acids as bulk chemicals,
particularly adipic acid, and which microorganisms we believe are
suitable to target for adipic acid production.
2.1. Requirements on industrial production host for adipic acid production
To be regarded as an interesting candidate for the industrial pro-
duction of an acid, the production host must fulﬁll several require-
ments, including production at a high titer, rate and yield. For acid
production, titer, rate and yield are in general required to be in the
range of 50–100 g/L, 1–3 g/L h−1 and > 0.5 g/g respectively (Wang
et al., 2016; Warnecke and Gill, 2005) to ensure an economically fea-
sible production. High yields can be obtained when the production host
can utilize all the available sugars, and the ﬂux towards the desired acid
is maximized, avoiding carbon losses in biomass and by-product for-
mation. The requirement on reaching titers of 50–100 g/L means that
the production host must tolerate the acid at such high concentrations.
From the cost perspective, it is beneﬁcial if the production host toler-
ates an acidic process condition, preferably around the pKa of the acid,
to avoid the formation of salts when a base is added to maintain the pH
thereby reducing the cost of downstream processing. The cost of
downstream processing can account for> 50% of the total product cost
(Wang et al., 2016), so it is important to reduce this as much as pos-
sible. For adipic acid the preferred process pH would then be ~4 since
adipic acid has a pKa of 4.4.
In addition, to further reduce the overall production cost, the pro-
duction host must be able to thrive in a simple and inexpensive
medium. For instance, the addition of vitamins or essential amino acids
increases the cost, and the use of a complex medium will make pur-
iﬁcation of the product costlier. Diﬀerent obstacles to fermentation will
be encountered depending on the source of the raw material.
Lignocellulosic raw materials are regarded as attractive raw materials
for fermentation since they are cheap, abundant and do not directly
compete with food production. However, lignocellulosic material is
very complex, containing cellulose, hemicellulose and extremely re-
calcitrant lignin. Therefore, pretreatment is often necessary to release
the sugars (pentoses and hexoses), to make them available for fer-
mentation, which increases the cost. Furthermore, inhibitors such as
acetic acid, furfurals and phenols are normally released during pre-
treatment (Olsson et al., 2005). To achieve the required titer, rate and
yield, the production host must also be tolerant to inhibitors present in
the medium.
2.2. Microorganisms suitable for production of adipic acid
Both natural and recombinant microorganisms can be used to pro-
duce acids via fermentation. A natural producer, if it exists, must ﬁrst
be identiﬁed; requiring knowledge on which habitat to search, which
growth conditions to apply, and feasible screening methods. For adipic
acid there are no known natural producer, although the bacterium
Thermobiﬁda fusca has been reported to naturally possess a pathway for
adipic acid. However, one endogenous enzyme was found to act as the
regulatory node and production of adipic acid was only observed in cell
lysates with addition of the enzyme (Deng and Mao, 2015). Although
natural producers have the advantage of producing the desired acid
without the need for genetic engineering, they will not necessarily be
successful on the industrial scale, as the titer may be too low, or it may
be intolerant to the acid produced (Gu et al., 1998). In fact, weak acids
are often used as food preservatives, and can exert product-mediated
inhibition. In addition, natural producers often suﬀer from non-char-
acterized genome and lack of molecular toolbox, potentially obstructing
metabolic engineering strategies. Another disadvantage of natural
producers is that a complex, and thus expensive, medium is often re-
quired for the organism to thrive (Mazzoli et al., 2014; Sauer et al.,
2008). The alternative to a natural producer is to create a recombinant
strain based on the cell chassis of a very well-characterized organism, in
which the metabolic pathway for the desired acid is heterologously
expressed. Metabolically engineered strains of E. coli, C. glutamicum and
S. cerevisiae are attracting considerable interest for production of var-
ious dicarboxylic acids. These three microorganisms are all extremely
well characterized, easy to cultivate, sequences are available for several
strains, and each has a well-equipped molecular toolbox. E. coli is
known to survive at pH down to 2, as it survives the conditions in the
mammalian stomach, but it is sensitive to a decrease in pH during ex-
ponential growth. Therefore, cultivation is normally carried out at near-
neutral pH, which is also the case for the gram-positive C. glutamicum.
S. cerevisiae, on the other hand, tolerates lower pH with an optimal pH
around 4–5 (Buzás et al., 1989). Concerning the above-mentioned re-
quirement for low-pH cultivation for economically feasible adipic acid
production, S. cerevisiae is an interesting microorganism to metaboli-
cally engineer for adipic acid production. In addition, S. cerevisiae is
already a well-established microorganism in the industry and used for
conversion of lignocellulosic biomass into ethanol and other products
(Rødsrud et al., 2012). However, bacterial chassis have often proven
superior, in terms of titer, rate and yield, to fungal chassis when me-
tabolically engineered for the production of an array of acids (Liu and
Jarboe, 2012). For direct production of adipic acid from glucose there
are only reports of bacterial producers, indicating that other limitations
must be overcome before S. cerevisiae can become an economically
feasible host for production of adipic acid.
3. Metabolic pathways to adipic acid
A large number of proven and theoretical metabolic pathways for
the production of adipic acids have been suggested. These include di-
rect and indirect production of adipic acid, where precursors are
formed in the latter, which are subsequently chemically transformed to
render adipic acid. The proposed and proven direct pathways are pre-
sented in Figs. 3 to 5, while the indirect pathways that produce the
precursors muconic acid and glucaric acid, are discussed in the fol-
lowing sections.
3.1. Direct pathways for adipic acid production
The pathways of direct production of adipic acid proven to work can
be divided into three large pathway branches: 1) the reverse adipate
degradation pathway (Babu et al., 2015; Deng and Mao, 2015;
Kallscheuer et al., 2017; Yu et al., 2014; Zhao et al., 2018), 2) a com-
bination of β-oxidation or reverse β-oxidation with the ω-oxidation
pathway (Beardslee and Picataggio, 2012; Clomburg et al., 2015), and
3) the 2-oxopimelic acid route (Turk et al., 2016) (Fig. 3).
3.1.1. The reverse adipate degradation pathway
The reverse adipate degradation pathway relies on the reverse of the
adipic acid degradation pathway naturally found in Penicillium chryso-
genum (Thykaer et al., 2002). This pathway has great potential since the
maximum theoretical yield is 0.92mol adipic acid/mol glucose, ac-
companied by a maximum ATP yield of 1.55mol/mol glucose, under
E. Skoog et al. Biotechnology Advances 36 (2018) 2248–2263
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both aerobic and anaerobic conditions (Burgard et al., 2016). This very
high yield is possible only if the precursor succinyl-CoA is derived from
the reverse operating TCA cycle, which does not form CO2. As a result
of this high theoretical yield, most eﬀorts directed at the production of
adipic acid via direct fermentation found in the literature have involved
the reverse adipate degradation pathway. E. coli (Babu et al., 2015;
Kallscheuer et al., 2017; Yu et al., 2014) and T. fusca (Deng and Mao,
2015) have been used as production hosts for the development of this
pathway. The pathways published are identical in terms of metabolic
intermediates from succinyl-CoA to adipyl-CoA, and include the con-
densation of succinyl-CoA and acetyl-CoA to form 3-oxoadipyl-CoA,
reduction to 3-hydroxyadipyl-CoA, dehydration to 5-carboxy-2-pente-
noyl-CoA, and reduction to adipyl-CoA (Fig. 3, blue pathway) (Babu
et al., 2015; Deng and Mao, 2015; Kallscheuer et al., 2017; Yu et al.,
2014). The enzymes able to carry out the reactions in this pathway have
been described and are summarized in Table 1. This metabolic pathway
is reported to be endogenous to T. fusca (Deng and Mao, 2015), how-
ever, the enzymatic step carried out by 5-carboxy-2-pentenoyl-CoA
reductase (responsible for the reduction to adipyl-CoA) was identiﬁed
as a bottleneck in this pathway. The transcription studies were carried
out in order to identify this protein as the bottleneck of the pathway
(Deng and Mao, 2015). Further, conversion of adipyl-CoA to adipate
has been investigated using various enzymes: 1) succinyl-CoA synthe-
tase (Deng and Mao, 2015), 2) acyl-CoA esterase (Babu et al., 2015) and
3) by two enzymatic steps by means of phosphate butyryltransferase
(phosphorylation of adipyl-CoA) and butyrate kinase (reduction of
adipyl-phosphate) (Yu et al., 2014).
Enzymes from diﬀerent organisms have been tested for the con-
struction of the reverse adipate degradation pathway in E. coli, both in
vitro and in vivo (Babu et al., 2015; Kallscheuer et al., 2017; Yu et al.,
2014), and several combinations of them have been used in attempts to
optimize the process. Recently, this pathway has been implemented in
E. coli for improved adipic acid production using glycerol as the major
carbon source (Zhao et al., 2018). In the mentioned study, adipic acid
production with 68 g/L with 0.81 g/L h−1 productivity and 0.378 g/g
yield was achieved. The highest results with glucose as carbon source
(0.05 mol adipic acid/mol substrate yield and 2.5 g/L titer) has been
obtained by ﬁne-tuning the natural pathway of T. fusca (Deng and Mao,
2015) (Table 2). It is worth noting that, NADH stoichiometry is better
with glycerol than glucose especially in the microaerobic conditions
(Zhao et al., 2018). This perhaps explains low titers of adipic acid
production with glucose as carbon source due to an imbalance in the
redox potential (Babu et al., 2015; Burgard et al., 2016; Yu et al., 2014).
A limitation in the availability of either acetyl CoA or succinyl-CoA, the
Fig. 3. Overview of the metabolic pathways for the direct production of adipic acid. Reverse adipate degradation pathway (blue), reverse β- then ω-oxidation
pathway (red), 2-oxopimelic acid pathway (purple), 3-oxoadipic acid pathway (brown), 2-oxoadipic acid alternatives (yellow), lysine alternatives (green). Enzymatic
activity has been demonstrated for the enzymatic steps indicated by full lines, while no proof of enzymatic activity has been demonstrated for enzymatic steps
indicated by dashed lines. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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Fig. 4. Metabolic pathways for the production of adipic acid that combine the β- and ω-oxidation pathways. Full lines indicate metabolic pathways starting with
acetyl-CoA which enters the reverse β-oxidation cycle to form carboxylic acid. The carboxylic acid subsequently enters the ω-oxidation pathway to form a di-
carboxylic acid. Dashed lines indicate pathways starting with a fatty acid (carboxylic acid), which is converted into dicarboxylic acid by means of the ω-oxidation
pathway. The dicarboxylic acid then enters the β-oxidation cycle and loses two carbons per cycle until adipic acid is formed.
Fig. 5. A) Polyketide pathway for the production of adipic acid. B) Invista's proposed pathway for the production of adipic acid from oxalyl-CoA. ACP: acyl-carrier-
protein; NAC: N-acetylcysteamine. Dashed lines indicate non-proven reactions, full lines indicate proven reactions. *The reaction has been demonstrated using
adipyl-CoA-ACP as substrate.
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two substrates required at a 1:1 ratio, would also be a limiting factor for
the overall rate of product formation. In fact, it has been pointed out
that optimization of the native pathways and regulatory mechanisms
for the formation of acetyl CoA and succinyl-CoA is crucial to increase
titers of adipic acid (Babu et al., 2015).
3.1.2. Combination of β-oxidation or reverse β-oxidation with ω-oxidation
pathway
The ω-, reverse β-, and β-oxidation pathways have been im-
plemented and combined in E. coli and in some Candida yeast species
(Fig. 3, red line and Fig. 4) to produce adipic acid. E. coli was grown on
glycerol as the carbon source (Clomburg et al., 2015), while Candida
spp. were grown on vegetable oil (e.g., coconut oil) (Beardslee and
Picataggio, 2012). In theory, the order in which ω-, reverse β-, or β-
oxidation takes place does not matter as long as the common goal is to
obtain bi-functional groups on a six‑carbon molecule. In the case of
Candida spp. developed by Verdezyne, ω-oxidation initially takes place
on fatty acids, thus the resulting molecules are di-carboxylic acid of
various lengths (Fig. 4, dashed line). These di-acids are degraded via β-
oxidation, which releases two carbons from the substrates per cycle, in
the form of acetyl-CoA. The selection of acyl-CoA oxidase (encoded by
POX5 in Candida spp.), the ﬁrst enzyme that is involved in β-oxidation,
determined the success of the strategy. This enzyme accepts di-acids of
various lengths, but fails to recognize adipic acid as a substrate since it
has a low aﬃnity towards it (Beardslee and Picataggio, 2012). POX4, an
isozyme of POX5, which accepts C4-C20 substrates, was deleted in the
production host, thus preventing the cells from degrading adipic acid.
In other words, sixteen‑carbon fatty acid substrate, palmitic acid, is
converted into hexadecanedioic acid via ω-oxidation, and subsequently
loses two carbons in each cycle of β-oxidation until adipic acid is
formed and excreted extracellularly. Moreover, in this approach, the
catalytic reactions taking part in the ω-oxidation pathway were iden-
tiﬁed, and the key enzymes overexpressed in order to obtain higher
productivity in the process. A titer of 50 g/L of adipic acid was achieved
(Table 2). Although the maximum theoretical yield is 0.85mol adipic
acid/mol coconut oil, the yield is reduced to 0.51mol adipic acid/mol
coconut oil when the fatty acids are oxidized. From an environmental
and economic point of view any loss of carbon is undesirable. To reduce
the loss of carbons the two carbons lost in each round of β-oxidation
needs to be fed back to form adipic acid via other pathways, e.g. via
reverse β-oxidation followed by ω-oxidation.
In the case where E. coli was used as the production host, elongation
of acetyl-CoA via reverse β-oxidation takes place prior to ω-oxidation
(Clomburg et al., 2015) (Fig. 4, continuous line). Here, the six‑carbon
carboxylic acid is produced ﬁrst by reverse β-oxidation, and subse-
quently converted into adipic acid via ω-oxidation. The enzymatic ac-
tivities required in this combined pathway were investigated (from
known enzymes reported in the literature to act on similar substrates)
and tested. Thiolase and thioesterase (enzymes responsible for the
condensation step and the elimination of CoA from carboxylic acid,
respectively) were considered key points in the pathway as they control
the carbon length of the substrate (Clomburg et al., 2015). The selection
of 3-ketoacyl-CoA thiolase encoded by bktB from Ralstonia eutropha
governed the synthesis of C6-C10 carboxylic acids without the synthesis
of longer-chain products. For thioesterase, the E. coli ydil gene was
selected, since it showed low speciﬁcity towards acetyl-CoA and bu-
tyryl-CoA, and a higher activity using C6, C8 and C10 acyl-CoA sub-
strates, which favored the subsequent production of the corresponding
dicarboxylic acids. However, to further increase the production of
adipic acid and avoid the formation of longer di-acids, the enzyme
speciﬁcities of all the aforementioned enzymes must be further opti-
mized. This metabolic route requires that the starting metabolites
acetyl-CoA and butyryl-CoA are present at equimolar concentrations.
Both the metabolic pathways described in this section also suﬀer from
redox imbalance.
3.1.3. The 2-oxopimelic acid pathway
The 2-oxopimelic acid pathway has been implemented in E. coli and
produces adipic acid as a by-product in the biosynthetic pathway in-
tended for the production of aminocaproic acid using glucose as
Table 1
The enzymes used in the reverse adipate degradation pathway using E. coli and T. fusca as production hosts. (This pathway corresponds to the blue pathway in Fig. 3.)
Reaction Substrate Product Enzyme Donor Host References
1. Condensation Acetyl-CoA and succinyl-
CoA
3-oxoadipyl-CoA PaaJ E. coli (native) E. coli Babu et al. (2015); Kallscheuer et al.
(2017); Yu et al. (2014)
Tfu_0875 T. fusca (native) T. fusca Deng and Mao (2015)
Tfu_0875 T. fusca E. coli Zhao et al. (2018)
2. Reduction 3-oxoadipyl-CoA 3-hydroxyadipyl-CoA PaaH1 (3-hydroxy acyl-CoA
reductase)
R. eutropha E. coli Yu et al., (2014)
PaaH E. coli (native) E. coli Kallscheuer et al. (2017)
Tfu_2399 T. fusca (native) T. fusca Deng and Mao (2015)
Tfu_2399 T. fusca E. coli Zhao et al. (2018)
3. Dehydration 3-hydroxyadipyl-CoA 5-carboxy-2-pentenoyl-
CoA
Crt (crotonase) Clostridium
acetobutylicum
E. coli Yu et al. (2014)
Ech (enoyl CoA hydratase) R. eutropha E. coli Yu et al. (2014)
PaaF E. coli (native) E. coli Kallscheuer et al. (2017)
Tfu_0067 T. fusca (native) T. fusca Deng and Mao (2015)
Tfu_0067 T. fusca E. coli Zhao et al. (2018)
4. Reduction 5-carboxy-2-pentenoyl-
CoA
Adipyl-CoA Ter (trans enoyl CoA
reductase)
Euglena gracilis E. coli Yu et al. (2014)
DcaA (acyl-CoA
dehydrogenase)
Acinetobacter baylyi E. coli Kallscheuer et al. (2017)
Acd (acyl-CoA
dehydrogenase)
Cupriavidus necator E. coli Kallscheuer et al. (2017)
Tfu_1647 T. fusca (native) T. fusca Deng and Mao (2015)
Tfu_1647 T. fusca E. coli Zhao et al. (2018)
5. Termination Adipyl-CoA Adipic acid Ptb-buk C. acetobutylicum E. coli Yu et al. (2014)
TesB (thioesterase) A. baylyi ADP1 E. coli Kallscheuer et al. (2017)
TesB E. coli E. coli Kallscheuer et al. (2017)
Acd (acyl-CoA
dehydrogenase)
Thermococcus
gammatolerans
E. coli Kallscheuer et al. (2017)
Tfu_2577 and Tfu2576 T. fusca (native) T. fusca Deng and Mao (2015)
Tfu_2577 and Tfu2576 T. fusca E. coli Zhao et al. (2018)
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substrate (Turk et al., 2016) (Fig. 3, purple line). The pathway starts
with 2-oxoglutaric acid, which is elongated to 2-oxoadipic acid by
means of the Aks enzymes (AksA, AksD, AksE, AksF) implicated in the
ketoacid elongation pathway in methanogenic archaea. While the re-
sulting 2-oxoadipic acid is subsequently elongated in the same manner
to form 2-oxopimelic acid then α-ketosuberate in these archaea, it stops
at 2-oxopimelic acid and does not proceed to form α-ketosuberate in the
synthetic pathway (Turk et al., 2016) (Fig. 3, purple line). Instead, the
pathway was ﬁne-tuned by the choice of the ﬁrst enzyme (AksA) in the
elongation cycle, partly responsible for the selection of the chain length
of the intermediates in the route. The subsequent pathway is based on
the degradation of branched-chain amino acids, in which aldehydes are
produced by decarboxylation from the corresponding α-ketoacid. Dif-
ferent decarboxylases were tested for the production of adipate semi-
aldehyde from 2-oxopimelic acid. While the intended pathway con-
sisted of decarboxylation of 2-oxopimelic acid and subsequent amino
transfer to produce 6-aminocaproic acid, an unknown endogenous en-
zyme was more eﬃcient than the aminotransferase reaction (Turk et al.,
2016). The higher rate of oxidation by the unknown enzyme, than
aminotransferase on adipate semialdehyde, resulted in a higher amount
of adipate being produced than 6-aminocaproic acid. A titer of 0.3 g/L
of adipic acid was achieved with this pathway (Table 2). In this
pathway, starting with 2-oxoglutarate, one net mol of NADH is con-
sumed for every mol of adipic acid produced, resulting in an imbalance
in the redox potential.
3.1.4. The polyketide pathway
Apart from metabolic engineering approaches, the production of
adipic acid using only puriﬁed enzymes or cell-free extracts has also
been studied in detail. While metabolic engineering enables micro-
organisms to produce value-added compounds in vivo, in vitro studies
using enzymes provide veriﬁcation of challenging steps in pathway
engineering and design.
The conversion of succinyl-CoA to adipic acid using the polyketide
synthase (PKS) system was reported in 2016 (Hagen et al., 2016). In
this case, the borrelidin PKS system from Streptomyces spp. was mod-
iﬁed for the in vitro synthesis of adipic acid from succinyl-CoA as the
starter unit and malonyl-CoA as an extender unit (Hagen et al., 2016)
(Fig. 5, A). The borrelidin PKS system was chosen because succinyl-CoA
was found to be extended to yield 3-hydroxy-adipyl-ACP by the ex-
tension module of borrelidin PKS in a previous study (Hagen et al.,
2014). The extension enzyme module consists of ketosynthase, acyl-
transferase, ketoreductase and acyl-carrier protein. In order to proceed
with the dehydration of 3-hydroxy-adipyl-ACP, the dehydratase domain
called BorDH2, from the second extension module from the borrelidin
PKS cluster was chosen. BorDH2 is the ﬁrst dehydratase domain in the
borrelidin PKS cluster, and it outperformed the dehydratases from
aureothin, indanomycin, nanchangmycin and spinosyn PKS clusters
(Hagen et al., 2016). The ketoreductase and enoyl reductase domains
were selected from the reductive loop of the spinosyn PKS cluster to
replace the native ketoreductase module. Subsequent release of adipic
acid from adipyl-ACP was then achieved by the thioesterase domain of
the erythromycin cluster. Although the above-mentioned study of in
vitro adipic acid production using puriﬁed enzymes reported very low
production titers (~ 0.3mg/L of adipic acid), it demonstrates an un-
paralleled example of pathway engineering by demonstrating a new
pathway and proving its reaction schemes. Since two equivalents of
NADPH are consumed for each adipic acid molecule produced, alle-
viating this redox imbalance will be beneﬁcial in future metabolic en-
gineering strategies.
3.1.5. Theoretical pathways
In the previous sections, direct metabolic pathways proven to
function were reviewed. However, a number of theoretical pathways
have been proposed for the direct production of adipic acid, although,
to the best of our knowledge, these have not been shown to function.
Theoretical pathways suggested for the direct production of adipic acid
will be reviewed in the following sections.
3.1.5.1. The 3-oxoadipic acid pathway. The ﬁrst enzymatic step of this
pathway is identical to that in the reverse adipate degradation pathway,
where acetyl-CoA and succinyl-CoA are condensed into the product 3-
oxoadipyl-CoA (Fig. 3, brown line). However, the pathways diﬀer in the
second step, and in the 3-oxoadipic acid pathway, the product 3-
oxoadipyl-CoA is released from CoA via 3-oxoadipyl-CoA transferase
forming the intermediate product 3-oxoadipic acid. The ﬁrst two
enzymatic steps in this pathway are identical to the two ﬁnal steps of
the degradation pathway for aromatic and chloroaromatic compounds,
operating in the reverse direction (Kaschabek et al., 2002; Nogales
et al., 2007). The enzymatic reactions from 3-oxoadipic acid follow the
same type of reactions as in the reverse adipate degradation pathway,
but in this case the substrates are not condensed to CoA (Fig. 3, brown
line). None of the enzymes required to convert 3-oxoadipic acid to
adipic acid has yet been found in nature, however, some candidate
genes have been suggested for each of these steps, although there is no
experimental evidence (Burgard et al., 2016). Identifying enzymes with
suﬃcient activity and speciﬁcity for these steps is the ﬁrst serious
challenge in implementing this pathway. Additional challenges are the
redox imbalance and the need for equimolar concentrations of the
starting substrates succinyl-CoA and acetyl-CoA. However, this
pathway has considerable potential since the maximum theoretical
yield is 0.92mol adipate/mol glucose under both anaerobic and aerobic
conditions, and the maximum ATP yield is 1.55mol/mol glucose,
which is unaﬀected by the conditions (aerobic or anaerobic) (Burgard
et al., 2016). However, the high yield can only be achieved if the
precursor succinyl-CoA is formed from the reverse operating TCA cycle,
since two mols of carbon are lost as CO2 for each mol succinyl-CoA
formed in the TCA cycle.
3.1.5.2. 2-oxoadipic acid pathways. One important metabolite proposed
to be part of several pathways to adipic acid is 2-oxoadipic acid
(Burgard et al., 2016; Parthasarathy et al., 2011; Turk et al., 2016)
(Fig. 3). This metabolite is derived from 2-oxoglutaric acid via 1C
elongation achieved by the enzymes homocitrate synthase,
homoaconitase and homoisocitrate dehydrogenase (Burgard et al.,
2016). One of the branches of this pathway proceeds through 2-
oxopimelic acid, as described in section “The 2-oxopimelic acid
pathway”, while another branch proceeds through lysine, and is
described below in the section on “Pathways starting with lysine”.
The remaining pathways, described in this section, are highly similar
and interlinked to the reverse adipate and 3-oxoadipic acid pathways,
but diﬀer in the position of the carbon that is modiﬁed (Fig. 3, yellow
line). In the 2-oxoadipic acid pathways the functional groups targeted
are located on the α‑carbon instead of the β‑carbon, as is the case in the
3-oxoadipic acid and reverse adipate degradation pathways. Due to the
loss of two CO2 molecules in the conversion from acetyl-CoA to adipic
acid, the maximum theoretical yield is 0.67mol adipic acid/mol
glucose under aerobic conditions, and is reduced to 0.45mol/mol
under anaerobic conditions (Burgard et al., 2016). Under aerobic
conditions the maximum ATP yield is 6.17mol/mol glucose, whereas
under anaerobic conditions it is negligible, which requires the organism
to utilize other means of generating the energy required for cell growth.
Although activity has been demonstrated for some of the enzymes in the
pathway proceeding through 2-hydroxyadipic acid (Parthasarathy
et al., 2011; Reitman et al., 2012; Suda et al., 1977; Suda et al.,
1976), none of the pathways has so far proven feasible for adipic acid
production, and challenges associated with enzyme speciﬁcities must
be addressed before adipic acid production via one of the 2-oxoadipic
acid pathways can be realized. Another limitation in these pathways is
that none of them is balanced regarding redox potential and the
regeneration of redox power must be addressed via other pathways,
leading to the risk of reducing the yield.
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Despite these limitations, a study on the conversion of 2-oxoadipic
acid to 2-hexenedioic acid was reported in 2011 (Parthasarathy et al.,
2011). Three enzymes, 2-hydroxyglutarate dehydrogenase (HgdH),
glutaconate CoA-transferase (GctAB) and 2-hydroxyglutaryl-CoA de-
hydratase (HgdC and HgdAB) collectively encoded by six genes, were
used for in vitro conversion of 2-oxoadipic acid to 2-hexenedioic acid
(Parthasarathy et al., 2011). HgdH and GctAB were obtained from
Acidaminococcus fermentans, while HgdC and HgdAB were obtained
from Clostridium symbiosum. The constructed pathway begins with 2-
oxoadipic acid, and proceeds by reduction to 2-hydroxyadipic acid,
activation to 2-hydroxyadipyl-CoA, dehydration to 5-carboxy-2-pente-
noyl-CoA, and, ﬁnally, the release of CoA yields 2-hexenedioic acid.
This study was inspired by the fact that very similar conversion of 2-
ketoglutarate to glutaconate takes place in certain microorganisms in
the orders Clostridiales and Fusobacteriales (Parthasarathy et al., 2011).
Moreover, a previous report by the same group described the produc-
tion of glutaconic acid (2-pentenedioic acid) by an engineered E. coli
strain using the same gene combination, illustrating the potential for in
vivo production (Djurdjevic et al., 2011). The ﬁnal and challenging
problem of the reduction of 2-hexenedioic acid to adipic acid remained
unsolved for several years, but is has recently been shown that anae-
robic enzymes can carry out this reaction (Joo et al., 2017).
3.1.5.3. Pathways starting with lysine. When considering a metabolic
pathway starting with lysine for the production of adipic acid, one
should consider the cost of lysine as the starting material. The economic
feasibility of a process that involves feeding a cultivation broth with
carbon sources such as hexose or glycerol together with lysine, will be
compromised as lysine is considerably more expensive (van Haveren
et al., 2008). However, if the pathway is used with lysine-producing
industrial organisms such as C. glutamicum and hexose or disaccharide
is used as the substrate feed, the economics should be improved,
making this more feasible for industrial application. Lysine production
with titers as high as 120 g/L and a productivity of 4.0 g/L h−1 has been
reported previously (Becker et al., 2011; Becker and Wittmann, 2012a,
2012b).
Application of the adipic acid pathway using lysine as an inter-
mediate has been described in a patent by Genomatica (Burgard et al.,
2016). This pathway consists of four enzymatic steps; the ﬁrst being the
removal of the α-amino group from lysine to yield 6-aminohex-2-enoic
acid, followed by reduction to yield 6-aminocaproic acid. The terminal
amino group is then removed, resulting in adipic acid semialdehyde,
which is oxidized to adipic acid (Fig. 3, green lines, right path). One
serious challenge associated with this pathway is that only one of the
four enzymes required is known to exist. In an attempt to overcome this
problem, an additional pathway has been proposed starting with lysine
(Karlsson et al., 2018). In this pathway, the order of the enzymatic
reactions is diﬀerent, resulting in other metabolites being formed. In
the ﬁrst enzymatic step the terminal amino group of lysine is removed
yielding allysine, which is subsequently oxidized to form 2-aminoadipic
acid. Thereafter, the α-amino group is removed forming hex-2-enedioic
acid, which is reduced to adipic acid (Fig. 3, green lines, left path).
Using this approach reduces the number of unknown enzymes to one
instead of three.
Lysine can be synthesized via either of two microorganism-speciﬁc
pathways, and the maximum theoretical yield depends on the pathway
used. In E. coli and C. glutamicum, the native pathway to lysine is via
aspartic acid, giving a maximum yield of 0.50mol adipic acid/mol
glucose under aerobic conditions. In S. cerevisiae, lysine is produced via
2-oxoadipic acid, giving a slightly lower maximum theoretical yield
than that through aspartic acid; 0.40mol adipic acid/mol glucose under
aerobic conditions (Murthy and Janardanasarma, 1999). If lysine were
to be produced under anaerobic conditions the maximum theoretical
yield would be decreased (Table 2) and ATP production would be
negligible. Despite the rather low maximum theoretical yield, the main
advantage of these pathways compared to many of the other proposed
pathways is that they are neutral in terms of redox potential, hence the
microorganism does not have to regenerate the redox cofactors via
other pathways, which would risk reducing the overall yield.
A slightly diﬀerent approach is described in a patent by Celexion
(Baynes et al., 2015). In the Celexion patent, lysine degradation to yield
2-oxoadipic acid is described and conversion to adipic acid is described
similarly as in other sections of this review.
3.1.5.4. Adipic acid via ω-oxidation of hexanoic acid from hexanoate-
producing organisms. It is also theoretically possible to utilize a host
microorganism that naturally produces hexanoic acid, a six‑carbon
monocarboxylic acid, as the product. Anaerobic microorganisms such
as Megasphaera elsdenii are known to produce hexanoic acid as the end
product (Roddick and Britz, 1997). The use of such a rumen bacteria for
the production of organic acids, oﬀering a route for nylon production,
has been suggested previously (Sauer et al., 2012), but has not yet been
realized. The ω-oxidation scheme can be theoretically applied to this
metabolism to convert hexanoic acid into adipic acid (Fig. 4, route from
carboxylic acid to dicarboxylic acid). As in the aforementioned reverse
β-oxidation pathway, ω-oxidation can be incorporated into bacteria
producing hexanoic acid. The problem would be that the redox balance
observed in the aforementioned ω-oxidation scheme would also be
present in this case. Although the metabolic engineering of M. elsdenii
for the production of adipic acid has not been reported, it is
theoretically possible, especially as it has been demonstrated in E. coli
in the combination of ω-oxidation and reverse β-oxidation (Clomburg
et al., 2015). The challenge would then be to correctly express ω-
oxidation enzymes such as AlkBGT and achieve high titers under
anaerobic conditions since M. elsdenii is an anaerobic organism. No
reports on correctly functioning AlkBGT genes in M. elsdenii could be
found in the literature.
3.1.5.5. Adipic acid via methyl-ester shielded carbon elongation. A
metabolic pathway has been proposed for the production of adipic
acid from the central metabolite oxalyl-CoA via two cycles of methyl-
ester shielded carbon chain elongation (Botes and Van Eck Conradie,
2015). This strategy is based on the use of enzymes able to catalyze
methyl-ester shielded dicarboxylic acid substrates.
This theoretical biosynthetic pathway starts with the formation of
oxalyl-CoA methyl ester from oxalyl-CoA by means of a methyl-
transferase (Fig. 5, B) (Lin, 2012). Oxalyl-CoA methyl ester is then
condensed with malonyl-ACP to give 3-oxo-succinyl- ACP methyl ester,
or with malonyl-CoA or acetyl-CoA to give 3-oxo-succinyl-CoA methyl
ester (Botes and Van Eck Conradie, 2015; Slater et al., 1998). A
four‑carbon chain aliphatic backbone is produced by the condensation
step.
The 3-oxo-succinyl-ACP methyl ester or 3-oxo-succinyl-CoA methyl
ester is then subjected to a reduction reaction, dehydration and then a
second reduction reaction, which renders succinyl-ACP methyl ester or
succinyl-CoA methyl ester (Bond-Watts et al., 2012; Botes and Van Eck
Conradie, 2015; Budde et al., 2010; Fukui et al., 1998). Another iden-
tical round of carbon elongation then takes place, which forms the
six‑carbon backbone (Fig. 5, B). Adipyl- ACP methyl ester or adipyl-CoA
methyl ester is then obtained.
The methyl ester group is then removed by means of pimelyl-ACP
methyl ester esterase, and adipyl- ACP or adipyl-CoA is formed (Botes
and Van Eck Conradie, 2015; Lin et al., 2010). Both metabolites can
ﬁnally be converted to adipic acid. Diﬀerent enzymes can be used for
the conversion to adipic acid: a thioesterase or a CoA-transferase, or a
reversible CoA-ligase or a combination of a dehydrogenase that forms
adipate semialdehyde and an aldehyde dehydrogenase that forms
adipic acid (Botes and Van Eck Conradie, 2015).
This proposed metabolic pathway suﬀers from metabolic constrains
since NADH- or NADPH-dependent enzymes are used for double bond
reduction. Moreover, most of the enzymatic reactions proposed have
not yet been demonstrated. The second part of the pathway (once the
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C6 intermediate is formed) resembles the reverse β-oxidation pathway,
apart from the fact that in this case the intermediate metabolites carry
the methyl ester group.
3.2. Indirect pathways for adipic acid production
In the previous section, we focused on the metabolic pathways that
render adipic acid directly, whereas in the present section we discuss
the metabolic pathways that have been thoroughly studied for the in-
direct production of adipic acid by production of the precursors mu-
conic and glucaric acid. In indirect production an additional chemical
step is required to obtain adipic acid.
3.2.1. Production of muconic acid
Biobased production of muconic acid has been thoroughly studied
as an indirect means of producing adipic acid owing to its facile con-
version into adipic acid using a catalyst of platinum on activated carbon
(Niu et al., 2002). However, the recent discovery of enoate reductases
able to convert muconic acid to adipic acid opens the possibility to
directly produce adipic acid through metabolic pathways using mu-
conic acid, although with very low eﬃciency so far (Chan Joo et al.,
2017; Raj et al., 2018; Sun et al., 2018).
Two main feedstocks have been used for muconic acid production,
D-glucose and aromatic compounds such as benzoate or toluene (lignin-
derived or petroleum-based raw materials) (Curran et al., 2013; Draths
and Frost, 1994; Vardon et al., 2015; Weber et al., 2012). The ﬁrst
metabolic pathway studied for the production of muconic acid from
glucose starts with 3-dehydroshikimate (DHS), an intermediate of the
shikimate pathway for the biosynthesis of aromatic amino acids
(Fig. 6). DHS is converted to protocatechuic acid (PCA) (by means of
DHS dehydratase), is subsequently transformed to catechol (by means
of a PCA decarboxylase) and ﬁnally converted to muconic acid (in a
step catalyzed by a catechol 1, 2-dioxygenase) (Fig. 6, reactions D-E-F).
In an in silico evaluation of sixteen diﬀerent metabolic pathways that
render adipic acid, the routes based on the 3-dehydroshikimate
pathway were found to be the most thermodynamically favourable over
large pH range and substrate concentration (Averesch et al., 2018).
The 3-dehydroshikimate pathway has been implemented in E. coli
and S. cerevisiae in which heterologous synthetic pathways have been
designed, and in Klebsiella pneumoniae, in which the pathway occurs
naturally. This pathway was ﬁrst attempted in E. coli, in which the three
heterologous genes aroZ (encoding for DHS dehydratase), aroY (en-
coding for PCA decarboxylase) from K. pneumoniae, and catA (encoding
catechol 1,2-dioxygenase) from Acinetobacter calcoaceticus were in-
troduced in three diﬀerent plasmids (Draths and Frost, 1994). Rela-
tively low concentrations of muconic acid were synthesized (2.4 g/L)
when using shake ﬂask cultivations. In a follow-up study using bior-
eactors in batch mode, the E. coli strain was further improved and the
complexity of the microbes was reduced to constructs possessing only a
single plasmid (Niu et al., 2002). The best strain engineered in this way
synthetized 36.8 g/L of muconic acid, and rendered a yield of 0.22mol/
mol. The maximum theoretical yield calculated for this pathway is
0.75mol/mol (Table 2) (Burgard et al., 2016).
The natural pathway in K. pneumoniae has been used for muconic
acid production (Jung et al., 2015). K. pneumoniae has native aromatic
amino acid synthesis and benzoate degradation pathways, which pro-
duce muconic acid as an intermediate. Wild-type K. pneumoniae does
not accumulate muconic acid since the intracellular carbon ﬂow does
Fig. 6. Metabolic pathways for muconic acid production from glucose and lignin-derived compounds. E4P, erythrose 4-phosphate; PEP, phosphoenolpyruvate;
DAHP, 3-deoxy-D-arabinoheptulosonate-7-phosphate; A, DAHP synthase; B, 3-dehydroquinate (DHQ) synthase; C, DHQ dehydratase; D, DHS dehydratase; E, PCA
decarboxylase; F, catechol 1,2-dioxygenase; G, 3-dehydroshikimate dehydrogenase; H, protocatechuate 3,4 dioxygenase; I, phenol monooxygenase; J, muconate
cycloisomerase; K, chorismate pyruvate-lyase; L, 4-hydroxybenzoic acid hydrolase; M, isochorismate synthase, isochorismatase and 2,3-dihydro-2,3-DHBA dehy-
drogenase; N, 2,3-dihydroxybenzoate decarboxylase; O, anthranilate synthase; P, anthranilate 1,2-dioxygenase; Q, isochorismate synthase; R, isochorismate pyruvate
lyase; S, salicylate 1-monoxygenase.
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not favor it. However, metabolic engineering strategies that involved
removing branched and/or degradation pathways and overexpressing
catechol 1,2-dioxygenase have been used in an attempt to improve the
accumulation of muconic acid. The developed strain produced 2.1 g/L
of muconic acid in ﬂask cultivation.
Finally, S. cerevisiae strains able to produce muconic acid were de-
veloped using the same heterologous metabolic pathway (Curran et al.,
2013; Weber et al., 2012). Curran et al. introduced the genes encoding
for DHS dehydratase from Podospora anserina, PCA decarboxylase from
Enterobacter cloacae and catechol 1,2-dioxygenase from Candida albi-
cans into yeast after assessing diﬀerent candidates. A titer of 0.14 g/L
was obtained from shake ﬂask cultures. In order to improve the pro-
duction of adipic acid in S.cerevisiae, a biosensor based evolution
strategy was used to evolve a strain that was able to produce 2.1 g/L of
muconic acid (Leavitt et al., 2017). Weber et al. used a slightly diﬀerent
means to construct the same synthetic pathway with three bacterial
enzymes (DHS dehydratase from Podospora anserina, PCA decarbox-
ylase from Klebsiella pneumoniae and catechol 1,2-dioxygenase from
Acinetobacter radioresistens), which resulted in a ﬁnal muconic acid
concentration of 0.0015 g/L. However, the titers obtained with S. cer-
evisiae were much lower than those produced by E. coli.
Recently, the enzymatic conversion of muconic acid to adipic acid
by diﬀerent enoate reductases has been described (Chan Joo et al.,
2017). This discovery opens the possibility of directly producing adipic
acid from glucose through the 3-dehydroshikimate pathway. In this
way, a proof of concept was established by the introduction of the
enoate reductase from Bacillus coagulans in a S. cerevisiae strain and the
development of a three-stage fermentation process that rendered low
titers of adipic acid (0.0026 g/L) (Raj et al., 2018). In another attempt,
0.027 g/L of adipic acid was produced under microaerobic conditions
when the enoate reductase from Clostridium acetobutylicum was in-
troduced in an E.coli strain (Sun et al., 2018). The indirect production of
adipic acid through muconic acid rendered higher titers that the direct
option so far. More eﬀort needs to be done for the direct production of
adipic acid through muconic acid can be considered a competitive
option.
In all the above cases, metabolic engineering that involved the re-
direction of carbon ﬂow and the optimization of enzyme expression
levels and activity was required to improve the yields. When inter-
mediate metabolite concentrations were measured, high levels of PCA
were detected in many cases. It thus became apparent that PCA dec-
arboxylase activity was rate limiting (Fig. 6, D). Diﬀerent strategies
have been tested to improve the PCA decarboxylase activity, such as
cloning into high-copy-number vectors or genomic integration (Curran
et al., 2013; Weber et al., 2012), although the enzyme activity still
constituted a bottleneck. Some recent studies have revealed that co-
expression of PCA decarboxylase with two genetically associated pro-
teins, one of which probably produces a ﬂavin-derived cofactor re-
quired by the enzyme, improved muconic acid production and reduced
PCA levels (Johnson et al., 2016; Sonoki et al., 2014).
Another key aspect is the deletion of the aroE gene (Draths and
Frost, 1994; Jung et al., 2015; Niu et al., 2002; Weber et al., 2012),
which encodes for shikimate dehydrogenase (Fig. 6, G). The interrup-
tion of the ﬂow to the aromatic amino acid synthesis pathway at this
point left DHS available for muconate production.
Other alternative pathways derived from chorismate (an inter-
mediate in the shikimate pathway) have also been investigated. One of
them produced muconic acid via anthranilate (Fig. 6, reactions O-P-F)
(Sun et al., 2013), the ﬁrst intermediate in the pathway for the bio-
synthesis of tryptophan. The introduction in E. coli of the gene encoding
anthranilate 1,2-dioxygenase that enabled the conversion of anthrani-
late to catechol, and the gene encoding catechol 1,2 dioxygenase which
further converts catechol to muconic acid, enabled the pathway to
muconic acid. Moreover, a glutamine regeneration system was in-
troduced (by expression of a glutamine synthase from E. coli). This
would facilitate the activity of anthranilate synthase (Fig. 6, reaction O)
which uses glutamine as amino group donor. Titers of 0.39 g/L of
muconic acid were achieved using glucose and glycerol as substrates in
shake ﬂask experiments (Sun et al., 2013).
Another similar pathway for muconic acid production was devel-
oped by the same group (Lin et al., 2014). In this approach, salicylic
acid production was established in E. coli by the introduction of the
enzymes isochorismate synthase and isochorismate pyruvate lyase (Lin
et al., 2013), which convert chorismate to isochorismate and iso-
chorismate to salicylic acid, respectively (Fig. 6, Q and R). Muconic acid
production was achieved by the additional expression of the genes
encoding salicylate 1-monooxygenase and catechol 1,2-dioxygenase
(part of the salicylate degradation pathway, Fig. 6, S and F), leading to
the production of 1.5 g/L using shake ﬂask cultivation (Lin et al., 2014).
Yet other alternative for muconic acid production related to the
shikimate pathway has been explored (Sun et al., 2014). This pathway
focuses on the production of 2,3-dihydroxybenzoic acid (an inter-
mediate in the native E. coli enterobactin biosynthesis pathway) from
chorismate and its further conversion to catechol and muconic acid
(Fig. 6, reactions M-N-F). The introduction of three genes encoding for
isochorismate synthase, isochorismate and 2,3-dihydro-2,3-DHBA de-
hydrogenase enabled the production of 2,3-dihydroxybenzoic acid from
chorismate. Further introduction of the genes encoding for 2,3-dihy-
droxybenzoic acid decarboxylase and catechol 1,2-dioxygenase (Sun
et al., 2013) allowed the production of muconic acid, rendering 0.48 g/
L of muconic acid in cultivations in shake ﬂasks.
In another pathway, p-hydroxybenzoate (PHB) was used as an in-
termediate to produce catechol (Pugh et al., 2014; Sengupta et al.,
2015). PHB is an intermediate in the ubiquinone pathway, which
branches out from chorismate in the aromatic amino acid pathway. This
route has been implemented in E. coli using glucose as substrate. In this
pathway, the intermediate chorismate can be converted to PHB (Fig. 6,
K). PHB is subsequently transformed to protocatechuate and to catechol
(Fig. 6, L and E). A titer of 0.63 g/L of catechol was produced in batch
bioreactors (Pugh et al., 2014), which can be further converted to
muconic acid. The engineering of the pathway included the over-
expression of the genes encoding endogenous chorismate pyruvate
lyase (Fig. 6, K), the oxygen- and NADPH-dependent 4-hydro-
xybenzoate hydrolyase and protocatechuate decarboxylase (Fig. 6, L
and E) (Pugh et al., 2014; Sengupta et al., 2015). Furthermore, deletion
of the genes involved in the further transformation of chorismate via
adjacent routes increased the yields obtained. A titer of 0.17 g/L of
muconic acid was produced from glucose in shake ﬂasks without any
nutrient supplementation (Sengupta et al., 2015).
Most of the described routes based on the shikimate pathway were
optimized by the overexpression of key genes. Overexpression and
regulation of the aroB and aroD genes, encoding 3-dehydroquinate
synthase and dehydratase, respectively, in the upstream pathway im-
proved muconic acid production (Fig. 6, B and C) (Draths and Frost,
1994; Niu et al., 2002; Sengupta et al., 2015; Sun et al., 2013; Weber
et al., 2012). Moreover, 3-deoxy-D-arabinoheptulosonate-7-phosphate
(DAHP) synthase, the ﬁrst enzyme in the pathway for aromatic amino
acid synthesis (Fig. 6, A), is an important regulatory node in the
pathway. The enzyme is regulated via feedback inhibition, while the
expression of each gene is regulated at the transcriptional level. A
number of strategies have been developed to overcome both forms of
regulation, such us the use of a mutated gene that encodes a feedback-
resistant isozyme of DAHP synthase (Curran et al., 2013; Luttik et al.,
2008; Niu et al., 2002; Weber et al., 2012), or the deletion of tran-
scriptional regulators (Jung et al., 2015).
Increasing the expression of the tkt gene encoding for a transketo-
lase involved in D-erythrose 4-phosphate (E4P) synthesis also had a
signiﬁcant impact on carbon ﬂow into the aromatic amino acid bio-
synthetic pathway, presumably by increasing the availability of E4P,
one of the two substrates for DAHP synthase (Fig. 6, A) (Curran et al.,
2013; Lin et al., 2014; Niu et al., 2002; Sengupta et al., 2015; Sun et al.,
2014). Increasing the supply of phosphoenolpyruvate (PEP) and E4P
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metabolites could also increased the yields (Draths and Frost, 1994;
Weber et al., 2012). Also, in the case of Klebsiella, the production of
muconic acid was further improved by deletion of the gene encoding for
muconate cycloisomerase (Fig. 6, J) (Jung et al., 2015).
The biosynthetic pathways for aromatic amino acids were blocked
in some cases, leaving the key intermediates available for muconic acid
production (Lin et al., 2014; Sengupta et al., 2015; Sun X., Lin Y.,
Huang Q., Yuan Q., 2013; Sun et al., 2014), although this led to the
need for nutrient supplementation, which increased the cost of the
medium and made scaling-up diﬃcult. Most of these pathways suﬀered
from other limitations such as intermediate toxicity (Lin et al., 2014;
Pugh et al., 2014; Sun et al., 2014). Developing a more resistant host or
introducing the pathway into a naturally resistant microorganism can
be considered. Finally, the fact that some of the pathways described
suﬀer from redox imbalance must also be taken into consideration.
Pseudomonas putida KT2440 has been engineered in order to pro-
duce muconic acid from lignin-derived aromatics. The resulting strain
was able to catabolize diﬀerent aromatics through the upper pathways
in the β-ketoadipate pathway. Catechol and protocatechuic acid are
central intermediates in these pathways (Fig. 6, PCA and catechol
branches). A wide range of lignin-derived aromatics present in lignin,
such as benzoate, caﬀeic acid, p-coumarate, coniferyl alcohol and
phenol, can be converted into catechol or protocatechuic acid and,
subsequently, into muconic acid using this funneling strategy (Vardon
et al., 2015). To engineer the strain, PCA 3,4 dioxygenase, which me-
tabolizes PCA to 3-carboxymuconate (Fig. 6, H), was replaced with PCA
decarboxylase (aroY from E. cloacae), which enabled the conversion of
PCA to catechol. Moreover, the gene encoding one of the catechol 1,2-
dioxygenases responsible for the conversion of catechol to muconic acid
was constitutively expressed by means of the tac promoter. Further
metabolism of catechol was limited by the deletion of the catBC gene.
Finally, genes encoding phenol monooxygenase from Pseudomonas
CF600 were inserted in order to enable the catabolism of phenol (a
major component of lignin) to muconic acid (Fig. 6, I). The performance
of the engineered strain was tested in fed-batch reactors using p-cou-
marate as a model lignin monomer, giving a titer of 13.5 g/L (Table 2).
Finally, muconic acid has also been produced from biomass-derived
lignin in shake ﬂask cultivation as proof of concept for lignin valor-
ization (Vardon et al., 2015). The production of muconic acid from
aromatics such as benzene obtained from non-renewable resources has
also been thoroughly studied (Xie et al., 2014).
3.2.2. Production of glucaric acid
The biological production of glucaric acid has been studied as an-
other indirect means of producing adipic acid (Fig. 7). A synthetic
pathway has been designed in E. coli that enabled glucaric acid pro-
duction using glucose as feedstock (Moon et al., 2009). The metabolic
pathway included the following genes: myo-inositol-1-phosphate syn-
thase (Ino1) from S. cerevisiae, myo-inositol oxygenase (MIOX) from
mice and uronate dehydrogenase (Udh) from P. syringae. In this
pathway, Ino1 (which requires NAD+ for activity, which is regenerated
during the isomerization reaction) was used to produce myo-inositol-1-
phosphate from glucose-6-phosphate. Subsequently, myo-inositol-1-
phosphate is hydrolytically dephosphorylated by an endogenous phos-
phatase to produce myo-inositol. MIOX can then convert myo-inositol to
D-glucuronic acid using molecular oxygen. Finally, Udh converts D-
glucuronic acid into D-glucaric acid. Udh, which showed a high ac-
tivity, was able to increase the carbon ﬂux through the pathway.
However, it requires NAD+ for catalysis, which causes an imbalance in
the redox potential in this pathway. D-glucaric acid concentrations over
1 g/L were obtained (Table 2).
The activity of MIOX was found to be limiting and led to the ac-
cumulation of the intermediate myo-inositol. Nevertheless, glucaric acid
titers were further improved (~2.5 g/L) by co-localization of the Ino1
and MIOX enzymes with protein scaﬀolds (which recruit the desired
enzymes). The results showed that the MIOX activity depended on the
number of Ino1 molecules co-localized. Hence, the increase in the
number of interaction domains targeting Ino1 led to a higher local
concentration of the MIOX substrate, myo-inositol, which led to MIOX
activation and subsequently, to higher titers of glucaric acid (Dueber
et al., 2009; Moon et al., 2010).
MIOX activity was further improved by two diﬀerent protein en-
gineering approaches. The expression of MIOX with the fusion tag
SUMO (Small Ubiquitin-like Modiﬁer) led to higher stability of the
enzyme and increased glucaric acid production to 4.8 g/L (Table 2). On
the other hand, the directed evolution of MIOX led to the identiﬁcation
of a small DNA fragment (which encodes for manX mRNA), whose
overexpression increased myo-inositol transport and thus the D-glucaric
titer (4.6 g/L) (Shiue and Prather, 2014). Furthermore, knockdown of
the phosphofructokinase activity, which increased the availability of
glucose-6-phosphate, led to an improvement in the titer of up to 42%
(Brockman et al., 2015).
Glucaric acid was produced in S. cerevisiae using the same metabolic
pathway (Chen et al., 2018; Gupta et al., 2016). Titers of 6 g/L were
achieved from myo-inositol when a more stable miox4 from Arabidopsis
thaliana and the udh gene from Pseudomonas syringae was introduced in
the genome through a high copy delta-sequence intregration strategy.
4. Discussion
Considerable eﬀorts are being made to develop the biobased pro-
duction of adipic acid in order to replace the current petrochemical
production route. Although processes based on fatty acids (Beardslee
and Picataggio, 2012) and glycerol (Zhao et al., 2018) have high titers,
signiﬁcant development is still required for the conversion of other raw
materials, such as sugars. In the search for cheap and abundant, sugar-
rich raw materials that do not compete with food production, lig-
nocellulose-derived biomass has emerged as an interesting alternative.
However, the use of lignocellulose as a raw material poses a number of
challenges due to its recalcitrance, making it diﬃcult to release the
sugars for fermentation. It also suﬀers from the presence of inhibitors
such as acetic acid, furfurals and phenols, which requires the identiﬁ-
cation of a suitable, robust production host. As a result of concerted
research eﬀorts over recent decades, lignocellulosic biomass is now
used industrially as the raw material for the production of ethanol with
yeasts (Rødsrud et al., 2012). The inherent and engineered tolerance of
yeasts to lignocellulosic-derived inhibitors makes them attractive as
production hosts for lignocellulosic-based processes. In addition, acids
are preferably produced at acidic pH to avoid salt formation, which
further complicates the costly downstream process. Acidic pH en-
vironments have long been known to be a habitat for yeasts. A recent
ﬁnding, that yeasts tolerate adipic acid at industrially relevant levels
under acidic conditions, in contrast to bacteria, provides further evi-
dence that yeasts may be an interesting choice for biobased production
of adipic acid (Karlsson et al., 2017). This tolerance may be due to the
fact that yeasts have compartments surrounded by membranes, while
bacteria do not, which may restrict transport between compartments in
yeast.
Despite the lower tolerance for acidic conditions there are known
bacteria capable of producing high titers of succinic acid (Okino et al.,
2008; Vemuri et al., 2002). Another interesting host could be the fungus
R. arrhizus already producing high titers of fumaric acid (Xu et al.,
2012). These fumaric acid or succinic acid producing hosts can be
further equipped with reverse degradation pathway so that high titer
succinic acid or fumaric acid can be ﬂuxed towards adipic acid. These
hosts are known to produce>100 g/L succinic acid or fumaric acid and
thus can be great potential candidates for producing adipic acid once
the ﬂux is eﬃciently re-directed. So far, no eﬃcient natural producer of
adipic acid has been found, and it therefore appears to be necessary to
engineer a recombinant producer to endow it with a metabolic pathway
for the production of adipic acid.
Assuming glucose is used as the starting metabolite, we have
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identiﬁed at least 8 diﬀerent direct and indirect metabolic pathways
with several variants from the literature. Several of these pathways
have signiﬁcant parts in common, and the suggested pathways typically
consist of a combination of inherent metabolic reactions (depending on
the host), with other steps that must be conferred heterologously. When
selecting the metabolic pathway to be engineered, one should thus
consider the inherent metabolic pathways of the production host. For
example, a host known for its overproduction of lysine should be se-
lected when the intention is to introduce a pathway for the production
of this metabolite. The indirect production of adipic acid, from glucaric
and muconic acid, has been successful when using sugars or lignin
derivatives as substrates. However, both require aeration, and addi-
tional downstream chemical processing after biological production to
obtain adipic acid. This is less attractive since these extra steps increase
the production cost. For the direct production of adipic acid from glu-
cose, the 2-oxopimelic pathway and reverse degradation pathway have
been functionally demonstrated. However, the reported titer, produc-
tion rates and yields for both these pathways are still far too low to be
industrially relevant, despite the high potential indicated by the max-
imum theoretical yield, at least for the reverse adipate degradation
pathway. Other direct pathways identiﬁed are still only theoretical, and
have not yet been functionally demonstrated.
All of the metabolic pathways presented here pose diﬀerent chal-
lenges. One of the main bottlenecks identiﬁed in direct metabolic
pathways is the lack of suitable enzymes that can perform the desired
reactions eﬃciently. In fact, several of the proposed, but not func-
tionally proven pathways, include enzymatic reactions where the en-
zyme required has not yet been identiﬁed. The emergence of massive
amounts of genomic information in recent years will hopefully facilitate
the identiﬁcation and characterization of the novel enzyme activities
required in the suggested pathways. Protein engineering techniques
may also be useful in optimizing the activity or speciﬁcity of known
enzymes.
During the course of this literature survey, one enzymatic reaction,
namely the reduction of 2-hexenedioic acid to adipic acid, emerged as a
key reaction in four diﬀerent pathways: the 3-oxoadipic acid pathway,
two of the alternative 2-oxoadipic acid pathways, and one of the lysine
pathway alternatives (Fig. 3). Until recently, there was no known en-
zyme for the reduction of 2-hexenedioic acid, which could be due to the
fact that 2-hexenedioic acid is rarely, if ever, found in nature. Recently,
Jeong Chan Joo and coworkers were the ﬁrst to demonstrate the
reduction of 2-hexenedioic acid using enoate reductases (Joo et al.,
2017). They also demonstrated the conversion of muconic acid to adipic
acid, which could potentially lead to the direct production of adipic
acid using a pathway for muconic acid production, hence avoiding a
costly, additional puriﬁcation step (Warnecke and Gill, 2005). How-
ever, the experiments were performed under anaerobic conditions,
which could limit the usefulness of the enoate reductases, depending on
the oxygen requirements of the selected pathway and host.
Another common problem we identiﬁed are the poor speciﬁcities of
thiolases and thioesterases for the generation of C6 metabolites, which
are involved in several of the experimentally demonstrated metabolic
pathways based on glucose. In the reverse adipate degradation and 3-
oxoadipic acid pathways, the thiolase responsible for the condensation
of the starting metabolites must exhibit speciﬁcity towards acetyl-CoA
and succinyl-CoA, whereas the thiolase in the reverse β-, and ω-oxi-
dation pathways must exhibit speciﬁcity towards acetyl-CoA and bu-
tyryl-CoA. The thioesterase responsible for the link between reverse β-,
and ω-oxidation must be speciﬁc to hexanoyl-CoA. Poorly deﬁned
speciﬁcities will render products of various chain lengths, as has been
found when attempting to introduce the reverse adipate degradation
and reverse β-, and ω-oxidation pathways (Cheong et al., 2016;
Clomburg et al., 2015). Therefore, careful selection of enzymes that
render C6 products is essential for adipic acid production. In addition,
the starting metabolites must be available at an equimolar ratio to
ensure a steady ﬂux through the reverse adipate degradation, 3-ox-
oadipic acid and reverse β-, and ω-oxidation pathways. The ﬂux will
thus be limited by the generation of the starting metabolite that is
metabolized at the slower rate. Also, the starting metabolite succinyl-
CoA must be generated by the reverse TCA cycle to allow for the high
yields estimated for the reverse adipate degradation and 3-oxoadipic
acid pathways (Burgard et al., 2016), otherwise, the formation of suc-
cinyl-CoA from the TCA cycle will lead to the loss of two carbons as CO2
for each succinyl-CoA molecule formed.
Another important ﬁnding of the present study is that some of the
successfully demonstrated metabolic pathways utilize CoA-bound me-
tabolic intermediates. Whether or not the use of CoA cofactors is ad-
vantageous for the host in the production of adipic acid has not been
elucidated, but it could be hypothesized that the high-energy thioester
linkage between CoA and the metabolite could facilitate energetically
unfavorable reactions. Another interesting aspect is that enzymes with
speciﬁcities for CoA-bound metabolites are known to be synthesized in
Fig. 7. Metabolic pathway for the production of D-glucaric acid from glucose. PTS, phosphoenolpyruvate-dependent phosphotransferase; PEP, phosphoenolpyruvate;
Ino1, myo-inositol-1-phosphate synthase; MIOX, myo-inositol oxygenase; Udh, uronate dehydrogenase.
E. Skoog et al. Biotechnology Advances 36 (2018) 2248–2263
2260
the cell, e.g. in the synthesis of fatty acids, and are therefore available
and known to perform the desired chemical reaction. Pathways uti-
lizing CoA-unbound metabolites have been less successful, which could
partially be due to the fact that they require as yet unidentiﬁed enzymes
to perform the reaction in question.
Several of the direct metabolic pathways suﬀer from redox im-
balance as they often utilize the cofactors NADH/NADPH as a source of
reducing power. For a pathway to be eﬃcient the redox potential must
be balanced, as an imbalance in the pathway must be counteracted
elsewhere, via other pathways, potentially reducing the overall yield,
and resulting in undesirable by-product formation. To overcome this
problem, the reducing power can be ﬁne-tuned so as to recirculate the
cofactors in order to achieve a better redox balance. If the recirculation
of cofactors is coupled with product formation, by-product formation
can be avoided.
One parameter often evaluated when selecting a metabolic pathway
is the maximum theoretical yield. The maximum theoretical yield gives
valuable information on whether a pathway has the potential to reach
the eﬃciency required. However, the maximum theoretical yield can be
determined in diﬀerent ways, using diﬀerent model organisms and
diﬀerent mathematical models and assumptions. Therefore, the max-
imum theoretical yield is not well deﬁned. In this review, most of the
maximum theoretical yields given were obtained from the Genomatica
patent (Burgard et al., 2016). However, other values reported for the
same pathway may be based on the use of a diﬀerent model organism
(Frost and Draths, 1995). To ensure an objective comparison between
the potential of diﬀerent pathways when using the maximum theore-
tical yield, one should thus compare values based on the selected target
host, using the same model and assumptions for all pathways.
5. Conclusions
No eﬃcient naturally occurring microorganisms for the production
of adipic acid have yet been identiﬁed. In this review, we have analyzed
several options for the production of adipic acid using pathway en-
gineering, suggesting maximum theoretical yields ranging from 0.20 to
0.92mol adipic acid/mol substrate, depending on the metabolic
pathway and substrate. A careful analysis of the possible metabolic
pathways revealed that they are highly interlinked, which oﬀers the
possibility of new combinations of metabolic pathways for the pro-
duction of adipic acid. However, most of these metabolic pathways
suﬀer from substantial challenges due to redox imbalance, manipula-
tion of central carbon metabolic pathways that may inﬂuence cellular
ﬁtness, or the fact that one or several enzymes in the pathway have not
yet been identiﬁed. In many cases, the speciﬁcity of the enzyme em-
ployed in the pathway needs to be improved.
Some adipic-acid-producing pathways have been experimentally
demonstrated using sugar as the substrate, although with limited suc-
cess. However, a fermentation process using E. coli as host and glycerol
as substrate produced up to 68 g/L of adipic acid. Also, a palm-oil-based
process has shown a titer of up to 50 g/L of adipic acid, although this
process has limitations in terms of sustainability. A common factor in
the experimentally demonstrated pathways is that most of them use
CoA-activated carbons in several metabolic conversion steps. We have
discussed several other options for direct adipic acid production, where
a careful analysis of these pathways indicates that enoate reductase is a
key enzyme. The recent discovery of enoate reductases able to produce
adipic acid from muconic acid and 2-hexenedioic acid introduces other
alternative pathways for adipic acid production, although more eﬀort
need to be done in order to achieve eﬃcient titers. Additionally, many
metabolic pathways or variants thereof harbor metabolites of industrial
interest which can also be targeted.
The route towards an eﬃcient fermentation pathway is not obvious,
and we conclude that the starting point should be the capability of the
chosen production host, and that one metabolic pathway should be
introduced through extensive strain development. The choice of
microbial production host should be based on the intended raw mate-
rial, the robustness of the microorganism in relation to the raw material
and its tolerance to adipic acid, its inherent metabolic capability con-
cerning the pathway in question, and on detailed knowledge about the
host. Although the development of eﬃcient production host for adipic
acid production is a challenging task, the successful implementation of
biobased production of adipic acid will make an important contribution
to the development of a biobased economy. It is hoped that this review
will provide the research community with a comprehensive analysis of
the state of the art regarding metabolic capabilities in this area.
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